Results 11 to 20 of about 725,377 (269)

Drug‐resistant epilepsy: Drug target hypothesis and beyond the receptors

open access: yesEpilepsia Open, 2022
Epilepsy is a chronic neurological disorder that affects more than 50 million people worldwide. Despite a recent introduction of antiseizure drugs for the treatment of epileptic seizures, one‐third of these patients suffer from drug‐resistant epilepsy ...
Daniel Fonseca‐Barriendos   +5 more
doaj   +1 more source

Interplay of miRNAs and Canonical Wnt Signaling Pathway in Hepatocellular Carcinoma

open access: yesFrontiers in Pharmacology, 2018
Hepatocellular carcinoma is one of the leading causes of cancer death worldwide and the activation of canonical Wnt signaling pathway is universal in hepatocellular carcinoma patients.
Xiaobo Nie   +5 more
doaj   +1 more source

Xenobiotic receptors in mediating the effect of sepsis on drug metabolism

open access: yesActa Pharmaceutica Sinica B, 2020
Sepsis is an infection-induced systemic inflammatory syndrome. The immune response in sepsis is characterized by the activation of both proinflammatory and anti-inflammatory pathways.
Chuanzhu Lv, Ling Huang
doaj   +1 more source

PET Imaging Radiotracers of Chemokine Receptors

open access: yesMolecules, 2021
Chemokines and chemokine receptors have been recognized as critical signal components that maintain the physiological functions of various cells, particularly the immune cells.
Santosh R. Alluri   +2 more
doaj   +1 more source

SYNERGISM AND DRUG-RECEPTOR

open access: yesJapanese Journal of Pharmacology, 1964
In the study of the drug-receptor interaction, the analysis of the mode of drugantagonism had been the objects of the principal interests, and the drug-synergism had only been remarked in passing (1). Veldstra (2) mentioned the relation between drug receptor and synergism in his extensive review on “Synergism and Potentiation”.
TAKAGI, KEIJIRO, TAKAYANAGI, ISSEI
openaire   +3 more sources

Nuclear receptors: a bridge linking the gut microbiome and the host

open access: yesMolecular Medicine, 2021
Background The gut microbiome is the totality of microorganisms, bacteria, viruses, protozoa, and fungi within the gastrointestinal tract. The gut microbiome plays key roles in various physiological and pathological processes through regulating varieties
Zixuan Wang   +2 more
doaj   +1 more source

GRK Mediates μ-Opioid Receptor Plasma Membrane Reorganization

open access: yesFrontiers in Molecular Neuroscience, 2019
Differential regulation of the μ-opioid receptor (MOP) has been linked to the development of opioid tolerance and dependence which both limit the clinical use of opioid analgesics.
Arisbel B. Gondin   +8 more
doaj   +1 more source

Visualizing Ligand Binding to a GPCR In Vivo Using NanoBRET

open access: yesiScience, 2018
Summary: The therapeutic action of a drug depends on its ability to engage with its molecular target in vivo. However, current drug discovery strategies quantify drug levels within organs rather than determining the binding of drugs directly to their ...
Diana C. Alcobia   +9 more
doaj   +1 more source

Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies

open access: yesActa Pharmaceutica Sinica B, 2021
Inflammatory bowel disease (IBD) is a chronic intestinal disease with painful clinical manifestations and high risks of cancerization. With no curative therapy for IBD at present, the development of effective therapeutics is highly advocated.
Peng Liu   +7 more
doaj   +1 more source

Structure-Function Analyses of Human Bitter Taste Receptors—Where Do We Stand?

open access: yesMolecules, 2020
The finding that bitter taste receptors are expressed in numerous tissues outside the oral cavity and fulfill important roles in metabolic regulation, innate immunity and respiratory control, have made these receptors important targets for drug discovery.
Maik Behrens, Florian Ziegler
doaj   +1 more source

Home - About - Disclaimer - Privacy